Company: MYGN
Filing Date: 2025-06-05
Form Type: 8-K
Source: 0000899923-25-000066
Chunk: 3

Company: MYRIAD GENETICS INC
Filing Date: 2025-06-05
Form: 8-K
Item: Item 9.01
Chunk 3
---
ITEM 9.01 Financial Statements and Exhibits.

  Exhibit      Description                                                                   
  Number                                                                                     
 ─────────────────────────────────────────────────────────────────────────────────────────────
  10.1+        2017 Employee, Director and Consultant Equity Incentive Plan, as amended      
  104          Cover Page Interactive Data File (embedded within the Inline XBRL document).  

(+) Management contract or compensatory plan arrangement

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

  MYRIAD GENETICS, INC.                               
  By:                        /s/ Scott J. Leffler     
                             Scott J. Leffler         
                             Chief Financial Officer